Skip to content

Pharmacological Reports

ISSN 1734-1140, 2299-5684

38 papers in the library · 471 citations · publishing 2011-2026

Papers

Sort Most recent Most cited

Psychedelics action and schizophrenia.

Pharmacological Reports October 30, 2023 Marzena Maćkowiak 20 citations

Abstract Psychedelics are compounds acting by serotonin 5-hydroxytryptamine (5-HT) 2A receptor activation and induce several behavioral responses. They are of special interest because of their positive effects on neuropsychiatric disorders (depression and posttraumatic stress disorder). However, several findings revealed that some psychedelic actions are similar to symptoms observed in...

DOI: 10.1007/s43440-023-00546-5 (opens in new tab) Full text (opens in new tab) Psychedelics Schizophrenia Consciousness Mental health

Cardiovascular safety of psychedelic medicine: current status and future directions

Pharmacological Reports October 24, 2023 Agnieszka Wsół 56 citations

Abstract Psychedelics are powerful psychoactive substances that alter perception and mood processes. Their effectiveness in the treatment of psychiatric diseases was known before their prohibition. An increasing number of recent studies, due to the indisputable resurgence of serotonergic hallucinogens, have shown their efficacy in alleviating depression, anxiety, substance abuse therapies, and...

Pharmacologic hyperreactivity of kappa opioid receptors in periaqueductal gray matter during alcohol withdrawal syndrome in rats.

Pharmacological Reports October 1, 2023 Priscila Vázquez-león, Abraham Miranda-Páez, Hugo Sánchez-Castillo et al.

Periaqueductal gray matter (PAG) is a brain region rich in kappa-opioid receptors (KOR). KOR in PAG mediates behavioral responses related to pain integration, and panic response, among others. Its participation in the addiction phenomena has been poorly studied. Hence, this preliminary study explored the pharmacological effects of KOR stimulation/blockade in dorsal-PAG (D-PAG) during alcohol...

Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

Pharmacological Reports February 20, 2021 Samuel Kohtala

Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain to drug addiction and post-traumatic stress disorder. The discovery of the rapid-acting antidepressant effects of ketamine has resulted in a surge of...

Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.

Pharmacological Reports December 1, 2020 Monika Herian, Adam Wojtas, Małgorzata Katarzyna Sobocińska et al. 19 citations

4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin (5-HT) receptor agonist with hallucinogenic properties. The aim of our research was to examine the role of the 5-HT2A, 5-HT2C and 5-HT1A serotonin receptor subtypes in 25I-NBOMe hallucinogenic activity and its effect on dopamine (DA), 5-HT and glutamate release in the rat frontal cortex. Hallucinogenic...

DOI: 10.1007/s43440-020-00181-4 (opens in new tab) Full text (opens in new tab) 25i-nbome 5-ht2a/2c/1a receptor antagonists Hallucinogenic activity Neurotransmission

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

Pharmacological Reports April 16, 2020 J. Kryst, Paweł Kawalec, Alicja Mikrut Mitoraj et al. 157 citations

Due to unmet clinical needs for efficient drugs with a rapid onset of antidepressant effects, we aimed to evaluate the efficacy of single-dose ketamine in different subgroups of patients with major depression and establish whether repeated ketamine administration could be a viable strategy to maintain treatment gains. Electronic databases (Medline via PubMed, Embase, Cochrane Library, Trip...

Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain.

Pharmacological Reports October 2019 Małgorzata Frankowska, Joanna Miszkiel, Lucyna Pomierny-Chamioło et al.

Several studies strongly support the role of the dopamine D2-like and glutamate mGlu5 receptors in psychostimulant reward and relapse. The present study employed cocaine or MDMA self-administration with yoked-triad procedure in rats to explore whether extinction training affects the drug-seeking behavior and the D2-like and mGlu5 receptor Bmax and Kd values in several regions of the animal...

DOI: 10.1016/j.pharep.2019.05.001 (opens in new tab) Full text (opens in new tab) Cocaine self-administration Dopamine d2-like receptor Extinction training Glutamate mglu5 receptor +2

The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.

Pharmacological Reports October 1, 2018 Karolina Noworyta-Sokołowska, Anna Maria Górska, Krystyna Gołembiowska 5 citations

According to the European Drug Report, the use of novel psychoactive substances (NPS) is constantly growing. NPS are widely abused by human adolescent subjects. 5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is one of the most frequently used hallucinogenic NPS. 5-MeO-DIPT intoxication results in hallucinations, vomiting, and tachycardia. Long-term exposure to 5-MeO-DIPT was reported to lead...

DOI: 10.1016/j.pharep.2018.04.001 (opens in new tab) Full text (opens in new tab) 5-Methoxy-N,N-Diisopropyltryptamine Adolescence Open field test

The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug.

Pharmacological Reports October 2018 Agnieszka Pałucha-Poniewiera

Over the past decade, ketamine has been one of the most commonly studied potential antidepressants. This is because it produces a spectacularly rapid and persistent therapeutic effect in people suffering from severe treatment-resistant depression (TRD), for which classical drugs are ineffective. Similar efficacy was demonstrated for scopolamine, a drug belonging to a completely different...

Acute behavioral effects of co-administration of mephedrone and MDMA in mice.

Pharmacological Reports April 2017 Barbara Budzynska, Agnieszka Michalak, Małgorzata Frankowska et al.

Abuse of more than one psychoactive drug is becoming a global problem. Our experiments were designed to examine the effects of a concomitant administration of 3,4-methylenedioxy-methamphetamine (MDMA) and mephedrone on depression- and anxiety-like behaviors and cognitive processes in Swiss mice. In order to investigate the drug interactions the forced swimming test (FST) - an animal model of...

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Pharmacological Reports June 1, 2016 Xi-Ling Jiang, Hong-Wu Shen, Ai-Ming Yu 13 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and harmaline are indolealkylamine (IAA) drugs often abused together. Our recent studies have revealed the significant effects of co-administered harmaline, a monoamine oxidase inhibitor (MAOI), on 5-MeO-DMT pharmacokinetics and thermoregulation. This study was to delineate the impact of harmaline and 5-MeO-DMT on home-cage activity in mouse models,...

DOI: 10.1016/j.pharep.2016.01.008 (opens in new tab) Full text (opens in new tab) 5-HT Receptor Harmaline Maoi 5-MEO-DMT Combination +14

Pharmacological activity of salvinorin A, the major component of Salvia divinorum.

Pharmacological Reports 2011 Joanna Listos, Alicja Merska, Sylwia Fidecka 52 citations

The hallucinogenic plant Salvia divinorum (i.e., "magic mint") is a member of the Sage family that has been historically used for divination and shamanism by the Mazatecs. Today, S. divinorum has become increasingly popular as a recreational drug for its hallucinogenic effects. The non-nitrogenous diterpene, salvinorin A, the major active component of S. divinorum, is responsible for the...

Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug.

Pharmacological Reports 2011 Jenny L Wiley, Rhys L Evans, Darren B Grainger et al.

Adolescents and young adults of both sexes are the primary consumers of "club" drugs; yet, most of the mechanistic preclinical research in this area has been performed in adult male rodents. The purpose of this study was to evaluate the acute and repeated effects of drugs that are commonly abused by adolescents in female adolescent and adult rats in a rodent model of behavioral sensitization....